Skip to main content
Sign In

University of Colorado Denver Hematology, Blood Cancer, Bone Marrow Transplant

 

Division Faculty


​The faculty of the Division of Hematology are responsible for teaching, clinical care and research in all aspects of Hematologic Disorders.  Our division has physicians and mid-level providers who are devoted primarily to clinical care and clinical research, physician scientists who divide their time between the lab and the clinic and scientists who spend their time focused primarily on laboratory research. 

Because we take such an integrated approach to the diagnosis, treatment and curing of blood disorders we are able to move treatments from the bench to the bedside in a significantly more timely fashion.  Our patients have access to cutting edge treatments because our physicians and scientists are on the forefront of research in this critical area of medicine.
 
We invite you to get to know our faculty members better by taking the time to browse through their individual pages. 
 
Chief, Division of Hematology
Craig T. Jordan, PhD

 Results From Hematology : Selected site
PictureNameDescription

​General Hematology

Dr. Allen has worked with Dr Stabler in establishing new methods for the diagnosis of vitamin B12 and folate deficiency, and has contributed to the growing awareness of the importance of homocysteine as an independent risk factor for vascular disease.

Blood Cancer & BMT Secondary - ​Pediatrics

Dr. Bernt is a physician-scientist who cares for children with leukemia and directs a laboratory research program studying leukemia biology and epigenetics.

Blood Cancer & BMT

Dr. Brewer leads the psychosocial team for the Bone Marrow Transplant program.  He works closely with Dr. Caspari to care for patients and families in the Blood Cancer Program.

Tyler W. Buckner, MD, MSc

General Hematology

Dr. Buckner provides care to children and adults with bleeding and clotting disorders.  His research aims to evaluate the effectiveness of various treatment strategies for bleeding and thrombosis, and he is involved in multiple clinical trials of new treatments for patients with these disorders.

Blood Cancer & BMT Secondary - Molecular Biology Program

Dr. Degregori is a leading expert in leukemia research and the Associate Director for Basic Science at the University of Colorado Cancer Center.

​General Hematology Secondary - Pediatrics

Dr. Di Paola is a physician-scientist who cares for children with blood diseases and supervises a laboratory research program focused on vascular biology and the genetics of blood disorders.

Patricia Ernst

​Blood Cancer & BMT Secondary - ​Pediatrics

Dr. Ernst directs laboratory research programs that focus on discovery of epigenetic regulatory mechanisms in leukemia and and in regulating stem cells to improve transplantation. An additional focus is the development of the hematopoietic system and the regulatory networks that coordinate self-renewal and differentiation.

Blood Cancer & BMT Secondary - ​Pediatrics

Dr. Graham is a basic and translational researcher and Leader of Research Emphasis Area in the Biology of Childhood Cancer for Children’s Hospital Colorado (CHCO).  Dr. Graham is board-certified pediatric oncologist and an active member of the Leukemia/Lymphoma Team at CHCO.

Blood Cancer & BMT

Dr. Gutman directs the Allogeneic Bone Barrow Transplant (BMT) program and is a leading expert in the use of umbilical cord blood derived stem cells for BMT.  He oversees a broad range of clinical programs and trials.

​General Hematology

Dr. Hassell is interested in the pathogenesis of sickle cell crisis and the recognition of new clinical entities in the fields of coagulation and endothelial cell function.

Blood Cancer & BMT

Dr. Jordan serves as the Chief of the Hematology Division and directs a research program focused on the development of novel therapies for the treatment of leukemia.

Tanisha Joshi, Ph.D.

​Blood Cancer & BMT

Dr. Tanisha Joshi is a Counseling Psychologist and an Assistant Professor at the University of Colorado Denver Anschutz Medical Campus.

Manali Kamdar, MD

Blood Cancer & BMT

​Blood Cancer & BMT Secondary - Pediatrics

Dr. Neff is a physician-scientist who cares for children with leukemia and directs a laboratory research program studying leukemia biology and epigenetics.

Blood Cancer & BMT

Dr. Pollyea is the Director of the adult Clinical Leukemia Program, and cares for patients with leukemia, myelodysplastic syndrome (MDS), and related diseases.  He leads multiple clinical trials to investigate new treatments for patients with blood cancer.

Blood Cancer & BMT Secondary - ​Pediatrics

Dr. Porter is a physician-scientist who cares for children with blood cancers and directs a laboratory research program focused on the development of new treatment modalities for blood cancer.

​Blood Cancer & BMT Secondary - Radiation Oncology

Dr. Rabinovitch is a professor of Radiation Oncology and works closely with the Hematology team to care for patients with various types of blood cancer.  She has been recognized multiple times as a 5280 magazine “Top Doctor.”

Blood Cancer & BMT

​​Dr. Robinson is an active clinical and basic investigator studying the molecular and genetic regulation of melanocyte development and melanoma, particularly the role of microRNAs in the regulation of melanoma associated genes. 

​General Hematology

Dr. Seligman has established the importance of iron transport and utilization by malignant cells as well as the utility of measuring soluble plasma transferrin receptor levels in the diagnosis of iron deficiency.​

Blood Cancer & BMT

Dr. Smith is the Associate Chief of Hematology and the Clinical Director for the Blood Cancer Program.  He is a highly experienced laboratory researcher and directs a program focused on the development of new therapeutic regimens.

​General Hematology

Dr. Stabler has worked with Dr. Allen in establishing new methods for the diagnosis of vitamin B12 and folate deficiency, and has contributed to the growing awareness of the importance of homocysteine as an independent risk factor for vascular disease.